Clinical trials: Stage I Breast Cancer AJCC v7

Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

• Completed
• Age: Up to 75 years
• Phase 2
• Surgery or procedure
• Results posted

This phase IIb trial studies how well alternative dosing of exemestane before surgery works in treating in postmenopausal patients with stage 0-II estrogen positive breast cancer.

Conditions

Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7

Trial name

NCT02598557

Testing

Exemestane, Laboratory Biomarker Analysis, Pharmacological Study

Where

5 sites in United States, Italy

Volunteers

180 people

Sponsor

National Cancer Institute (NCI)